180 related articles for article (PubMed ID: 23896933)
41. Asymmetric catalytic ene-cyclization approach to 2-fluoro-19-nor-1,25-dihydroxyvitamin D(3) A-ring analog with significant transactivation activity.
Mikami K; Ohba S; Ohmura H; Kubodera N; Nakagawa K; Okano T
Chirality; 2001 Jul; 13(7):366-71. PubMed ID: 11400190
[TBL] [Abstract][Full Text] [Related]
42. Effects of fluorines on nonsecosteroidal vitamin D receptor agonists.
Kashiwagi H; Ohta M; Ono Y; Morikami K; Itoh S; Sato H; Takahashi T
Bioorg Med Chem; 2013 Feb; 21(3):712-21. PubMed ID: 23266184
[TBL] [Abstract][Full Text] [Related]
43. 22S-butyl-1alpha,24R-dihydroxyvitamin D3: recovery of vitamin D receptor agonistic activity.
Inaba Y; Nakabayashi M; Itoh T; Yoshimoto N; Ikura T; Ito N; Shimizu M; Yamamoto K
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):146-50. PubMed ID: 20211257
[TBL] [Abstract][Full Text] [Related]
44. Vitamin D receptor ligands for osteoporosis.
Cheskis BJ; Freedman LP; Nagpal S
Curr Opin Investig Drugs; 2006 Oct; 7(10):906-11. PubMed ID: 17086935
[TBL] [Abstract][Full Text] [Related]
45. Structural changes of vitamin D receptor induced by 20-epi-1alpha,25-(OH)2D3: an insight from a computational analysis.
Sicinska W; Rotkiewicz P
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):253-8. PubMed ID: 19429430
[TBL] [Abstract][Full Text] [Related]
46. Molecular tools for study of genomic and rapid signal transduction responses initiated by 1 alpha,25(OH)(2)-vitamin D(3).
Norman AW; Bishop JE; Bula CM; Olivera CJ; Mizwicki MT; Zanello LP; Ishida H; Okamura WH
Steroids; 2002 May; 67(6):457-66. PubMed ID: 11960621
[TBL] [Abstract][Full Text] [Related]
47. Dietary restriction of calcium, phosphorus, and vitamin D elicits differential regulation of the mRNAs for avian intestinal calbindin-D28k and the 1,25-dihydroxyvitamin D3 receptor.
Meyer J; Fullmer CS; Wasserman RH; Komm BS; Haussler MR
J Bone Miner Res; 1992 Apr; 7(4):441-8. PubMed ID: 1376958
[TBL] [Abstract][Full Text] [Related]
48. Three-dimensional structure-function relationship of vitamin D and vitamin D receptor model.
Yamada S; Yamamoto K; Masuno H; Choi M
Steroids; 2001; 66(3-5):177-87. PubMed ID: 11179725
[TBL] [Abstract][Full Text] [Related]
49. Atom-based and Pharmacophore-based 3D - QSAR Studies on Vitamin D Receptor (VDR).
Nagamani S; Kesavan C; Muthusamy K
Comb Chem High Throughput Screen; 2018; 21(5):329-343. PubMed ID: 29874993
[TBL] [Abstract][Full Text] [Related]
50. Apo- and Antagonist-Binding Structures of Vitamin D Receptor Ligand-Binding Domain Revealed by Hybrid Approach Combining Small-Angle X-ray Scattering and Molecular Dynamics.
Anami Y; Shimizu N; Ekimoto T; Egawa D; Itoh T; Ikeguchi M; Yamamoto K
J Med Chem; 2016 Sep; 59(17):7888-900. PubMed ID: 27535484
[TBL] [Abstract][Full Text] [Related]
51. Crystal structures of complexes of vitamin D receptor ligand-binding domain with lithocholic acid derivatives.
Masuno H; Ikura T; Morizono D; Orita I; Yamada S; Shimizu M; Ito N
J Lipid Res; 2013 Aug; 54(8):2206-2213. PubMed ID: 23723390
[TBL] [Abstract][Full Text] [Related]
52. Specific interactions between vitamin-D receptor and its ligands: Ab initio molecular orbital calculations in water.
Takeda R; Kobayashi I; Shimamura K; Ishimura H; Kadoya R; Kawai K; Kittaka A; Takimoto-Kamimura M; Kurita N
J Steroid Biochem Mol Biol; 2017 Jul; 171():75-79. PubMed ID: 28242261
[TBL] [Abstract][Full Text] [Related]
53. A vitamin D receptor selectively activated by gemini analogs reveals ligand dependent and independent effects.
Huet T; Laverny G; Ciesielski F; Molnár F; Ramamoorthy TG; Belorusova AY; Antony P; Potier N; Metzger D; Moras D; Rochel N
Cell Rep; 2015 Feb; 10(4):516-26. PubMed ID: 25620699
[TBL] [Abstract][Full Text] [Related]
54. CD-ring modified vitamin D3 analogs and their superagonistic action.
Eelen G; Verlinden L; Bouillon R; De Clercq P; Muñoz A; Verstuyf A
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):417-9. PubMed ID: 20132886
[TBL] [Abstract][Full Text] [Related]
55. Structure of the ligand-binding domain of rat VDR in complex with the nonsecosteroidal vitamin D3 analogue YR301.
Kakuda S; Okada K; Eguchi H; Takenouchi K; Hakamata W; Kurihara M; Takimoto-Kamimura M
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Nov; 64(Pt 11):970-3. PubMed ID: 18997319
[TBL] [Abstract][Full Text] [Related]
56. Ligand binding domain of vitamin D receptors.
Rochel N; Moras D
Curr Top Med Chem; 2006; 6(12):1229-41. PubMed ID: 16848737
[TBL] [Abstract][Full Text] [Related]
57. Relationship between Structure and Conformational Change of the Vitamin D Receptor Ligand Binding Domain in 1α,25-Dihydroxyvitamin D3 Signaling.
Wan LY; Zhang YQ; Chen MD; Du YQ; Liu CB; Wu JF
Molecules; 2015 Nov; 20(11):20473-86. PubMed ID: 26593892
[TBL] [Abstract][Full Text] [Related]
58. Design and synthesis of tetraol derivatives of 1,12-dicarba-closo-dodecaborane as non-secosteroidal vitamin D analogs.
Fujii S; Kano A; Masuno H; Songkram C; Kawachi E; Hirano T; Tanatani A; Kagechika H
Bioorg Med Chem Lett; 2014 Sep; 24(18):4515-4519. PubMed ID: 25149512
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological activity of two C-7 methyl analogues of vitamin D.
Sokolowska K; Carballa D; Seoane S; Pérez-Fernández R; Mouriño A; Sicinski RR
J Org Chem; 2015 Jan; 80(1):165-73. PubMed ID: 25396296
[TBL] [Abstract][Full Text] [Related]
60. Modulators of vitamin D nuclear receptor: recent advances from structural studies.
Belorusova AY; Rochel N
Curr Top Med Chem; 2014; 14(21):2368-77. PubMed ID: 25486941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
